1Y Close · As of Aug 26, 2026
KolmarBNH operates in the Pharmaceuticals sector.
Legal name: KolmarBNH Co., Ltd
In fiscal year 2025, KolmarBNH (200130) reported revenue of 574.9 billion KRW, down 6.6% from 615.6 billion KRW a year earlier.
Operating profit was 26.6 billion KRW and net income was -22.6 billion KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 273.9 billion KRW, with a P/B of 0.77.
These figures can be verified in the DART filing (receipt no. 20260317000761).
Financials
| Year | Rev | Op Inc | Net Inc |
|---|---|---|---|
| 2025 | 574.9B | 26.6B | -22.6B |
| 2024 | 615.6B | 24.6B | 17.2B |
| 2023 | 579.6B | 30.3B | 18.7B |
Recent Filings
Large Group Status Disclosure (Quarterly Disclosure Individual)
Semi-Annual Report (2026.06)
Payment and Dispute Resolution
Checks
No items require attention at this time.
Market Cap & Price: Market cap is above the delisting threshold.
Administrative Designation: No administrative designation criteria met.
Audit Opinion: Audit opinion: Unqualified (clean).
Convertible Bonds: No convertible bonds outstanding.
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: Treasury stock filings in the last 3 years: 1 cancellation(s).
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Market Action: No market actions recorded in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-28 | Large Group Status Disclosure (Quarterly Disclosure Individual) |
| 2026-08-14 | Semi-Annual Report (2026.06) |
| 2026-08-14 | Payment and Dispute Resolution |
| 2026-08-12 | Acquisition of Other Shares |
| 2026-08-12 | Share Retirement Decision |